These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 39056345)

  • 1. Midterm Outcomes of Percutaneous Intramyocardial Septal Radiofrequency Ablation for Hypertrophic Cardiomyopathy: A Single-Center, Observational Study.
    Xie X; Chen S; Cui Y; Zhou Z; Lu J; Du Z; Ding J; Xing K; Zhang Y; Zhou Y; Li J; Guo X
    J Am Heart Assoc; 2024 Aug; 13(15):e034080. PubMed ID: 39056345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Percutaneous Intramyocardial Septal Radiofrequency Ablation in Patients With Drug-Refractory Hypertrophic Obstructive Cardiomyopathy.
    Zhou M; Ta S; Hahn RT; Hsi DH; Leon MB; Hu R; Zhang J; Zuo L; Li J; Wang J; Wang B; Zhu X; Liu J; Han Y; Li X; Xu B; Zhang L; Hou L; Han C; Liu J; Liu L
    JAMA Cardiol; 2022 May; 7(5):529-538. PubMed ID: 35353129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial perfusion improvement and mechanism after percutaneous intramyocardial septal radiofrequency ablation in obstructive hypertrophic cardiomyopathy: a study of myocardial contrast echocardiography.
    Yao L; Ta S; Wang J; Han C; Lei C; Li W; Li J; Wang B; Zhao X; Liu L
    Int J Cardiovasc Imaging; 2024 Jul; 40(7):1483-1492. PubMed ID: 38709352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Efficacy and safety of transthoracic echocardiography-guided percutaneous intramyocardial septal radiofrequency ablation for the treatment of patients with obstructive hypertrophic cardiomyopathy].
    Liu LW; Zuo L; Zhou MY; Li J; Zhou XD; He GB; Zhang J; Zhang JZ; Liu B; Yang J; Xu B
    Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Apr; 47(4):284-290. PubMed ID: 31060187
    [No Abstract]   [Full Text] [Related]  

  • 5. Analysis of risk factors for complications in echocardiography-guided percutaneous intramyocardial septal radiofrequency ablation.
    Wang H; Cheng J; Chen Q; Pu Z; Li H
    J Cardiothorac Surg; 2024 Jul; 19(1):454. PubMed ID: 39014445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous Intramyocardial Septal Radiofrequency Ablation for Hypertrophic Obstructive Cardiomyopathy.
    Liu L; Li J; Zuo L; Zhang J; Zhou M; Xu B; Hahn RT; Leon MB; Hsi DH; Ge J; Zhou X; Zhang J; Ge S; Xiong L
    J Am Coll Cardiol; 2018 Oct; 72(16):1898-1909. PubMed ID: 30309466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous intramyocardial septal radiofrequency ablation after 5-year follow-up.
    Ta S; Li J; Hsi DH; Hu R; Lei C; Shan B; Li W; Wang J; Wang B; Kang N; Li X; Liu J; Qi C; Huang J; Han Y; Ruan F; Zhang J; Liu L
    Heart; 2024 May; 110(11):792-799. PubMed ID: 38388470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial mechanics of percutaneous intramyocardial septal radiofrequency ablation.
    Li J; Zhang J; Shi Y; Sievert H; Taub CC; Bertog S; Ta S; Changhui L; Senser E; Wang J; Hu R; Huang J; Ruan F; Han Y; Li X; Wang B; Zhao X; Liu J; Hsi DH; Liu L
    Heart; 2023 Jan; 109(4):289-296. PubMed ID: 36270787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concomitant ablation for atrial fibrillation during septal myectomy in patients with hypertrophic obstructive cardiomyopathy.
    Bogachev-Prokophiev AV; Afanasyev AV; Zheleznev SI; Pivkin AN; Fomenko MS; Sharifulin RM; Karaskov AM
    J Thorac Cardiovasc Surg; 2018 Apr; 155(4):1536-1542.e2. PubMed ID: 28947201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel approach in the use of radiofrequency catheter ablation of septal hypertrophy in hypertrophic obstructive cardiomyopathy.
    Shelke AB; Menon R; Kapadiya A; Yalagudri S; Saggu D; Nair S; Narasimhan C
    Indian Heart J; 2016; 68(5):618-623. PubMed ID: 27773399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [One-year follow-up after echocardiographically-guided percutaneous septal ablation in hypertrophic obstructive cardiomyopathy].
    Seggewiss H; Faber L; Ziemssen P; Gleichmann U
    Dtsch Med Wochenschr; 2001 Apr; 126(15):424-30. PubMed ID: 11347004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short time effects of two radiofrequency ablation methods on hypertrophic obstructive cardiomyopathy.
    He YG; Dong Y; Yang SH; Yang F; Yin JL; Zhao HQ; Zhao YJ
    Clin Cardiol; 2024 Feb; 47(3):e24217. PubMed ID: 38439605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-world clinical outcomes of percutaneous transluminal septal myocardial ablation for patients with drug-refractory hypertrophic obstructive cardiomyopathy: results from a retrospective multicenter registry of non-high-volume centers.
    Nakamura K; Toba T; Otake H; Kakizaki S; Fujimoto D; Takahashi Y; Fukuyama Y; Kawamori H; Tanaka H; Takaya T; Iwasaki M; Kozuki A; Kawai H; Hayashi T; Shite J; Hirata KI
    Heart Vessels; 2022 Nov; 37(11):1937-1946. PubMed ID: 35641828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical value of 2D speckle tracking imaging in evaluating the effect of percutaneous intramyocardial septal radiofrequency ablation in patients with hypertrophic obstructive cardiomyopathy.
    Qian D; Zhou X; Liu H; Cao L
    J Clin Ultrasound; 2021 Jul; 49(6):554-562. PubMed ID: 33675543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of coil embolization of the septal perforator for septal ablation in patients with hypertrophic obstructive cardiomyopathy.
    Guerrero I; Dhoble A; Fasulo M; Denktas AE; Sami S; Choi S; Balan P; Arain SA; Smalling RW
    Catheter Cardiovasc Interv; 2016 Nov; 88(6):971-977. PubMed ID: 27511120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results and 3-month follow-up in 25 patients.
    Seggewiss H; Gleichmann U; Faber L; Fassbender D; Schmidt HK; Strick S
    J Am Coll Cardiol; 1998 Feb; 31(2):252-8. PubMed ID: 9462563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complete heart block: determinants and clinical impact in patients with hypertrophic obstructive cardiomyopathy undergoing nonsurgical septal reduction therapy.
    Chang SM; Nagueh SF; Spencer WH; Lakkis NM
    J Am Coll Cardiol; 2003 Jul; 42(2):296-300. PubMed ID: 12875767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two severe complications post-percutaneous intramyocardial septal radiofrequency ablation in a patient with failed alcohol septal ablation: pulseless electrical activity cardiac arrest and pericardial tamponade-a case report.
    Shu T; Shen C; Chen X; Yu F
    Eur Heart J Case Rep; 2023 Aug; 7(8):ytad371. PubMed ID: 37637089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiofrequency septal reduction in symptomatic hypertrophic obstructive cardiomyopathy.
    Crossen K; Jones M; Erikson C
    Heart Rhythm; 2016 Sep; 13(9):1885-90. PubMed ID: 27132152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of radiofrequency ablation for hypertrophic obstructive cardiomyopathy: A systematic review and meta-analysis.
    Yang H; Yang Y; Xue Y; Luo S
    Clin Cardiol; 2020 May; 43(5):450-458. PubMed ID: 32034788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.